Pfizer fine: $2.3 billion. Result: Who cares?
Posted in Public Relations, Reputation Management, Public Policy, Advertising, Channel Marketing, Medical Marketing, Science, Legal, Marketing Promotion on Oct 19th, 2009 No Comments »
Author: Jason Voiovich Ecra Creative Group
Key Points: 1. The US Justice Department fined Pfizer $2.3 billion for illegal marketing practices; taking doctors on golf trips, paying for massages, and the like to encourage off-label prescriptions of popular drugs. 2. With such a hefty penalty, conventional wisdom would say Pfizer’s market perception should suffer. By objective measures, that is not happening. 3. Pfizer has insulated its corporate brand by positioning its blockbuster drugs as the stars, and not marketing itself. That seems to be working. For now.
Remember the dad in “My Big Fat Greek Wedding”?
He used Windex® for everything. He went so far as to carry around a bottle at all times, spraying things (and people) at comically inopportune times. Clearly, neither the FDA nor our friends at S.C. Johnson and Company in Racine, Wisconsin endorse Windex for the treatment of cold, flu, arthritis, and acne. The depiction was so ridiculous, most (reasonable consumers) wouldn’t take it seriously.
Now, let’s change the scenario.
Imagine you are recovering from a surgical procedure. Let’s pick appendix removal, but it could be anything. Clearly, you’re in pain, and your attending physician prescribes a medication - in this case, Bextra®. She tells you to take the prescribed dosage as needed and come back in three weeks.
Let me ask you something: In that scenario, do you look up the drug name in the formulary? Did you learn your doctor just prescribed well beyond the recommended dosage? Did you also learn Bextra; was not approved to treat post operative pain? That is was really an arthritis drug? And a Cox-2 inhibitor? The same Cox-2 inhibitor class of drugs you’ve heard about?
But your doctor knows best, right? (more…)







